Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title UPADACITINIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYLENOL REGULAR STRENGTH
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADALIMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title EDARBI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title EPIRUBICIN HYDROCHLORIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HERCEPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OMALIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ELTROMBOPAG OLAMINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VYLOY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title GAZYVA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HERCEPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SAXENDA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADVIL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REPATHA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NINTEDANIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LENALIDOMIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ADDERALL XR
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title PREGABALIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HERCEPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INFLIXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HUMIRA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VIMPAT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VENETOCLAX
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title WEGOVY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CERTOLIZUMAB PEGOL
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HERCEPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FINTEPLA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ACETAMINOPHEN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HERCEPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title COLUMVI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FOSCARBIDOPA\FOSLEVODOPA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SKYRIZI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OLAPARIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DULOXETINE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OSIMERTINIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZURZUVAE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title GOLIMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title QUETIAPINE FUMARATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title INFLIXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RISPERIDONE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ZURZUVAE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ICOTYDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRASTUZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RYBREVANT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title REPATHA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DYSPORT
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OPDIVO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HERCEPTIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SPRAVATO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology